Epithalon for Telomere Support — Aging
Epithalon peptide protocol for telomere maintenance and cellular senescence modulation in aging research.
Overview
Epithalon is a synthetic tetrapeptide that influences telomere biology and cellular aging processes. Clinical trial (n=162) demonstrated 90% positive effect in retinitis pigmentosa with no adverse effects. Human fibroblast studies show telomerase activation and telomere elongation, extending replicative lifespan. Cohort studies (n=266, 6-year follow-up) showed 1.6-4.1× mortality reduction. Cardiovascular study (n=79, 12-year follow-up) demonstrated 28% lower mortality and 50% cardiovascular mortality reduction. Most research conducted by Khavinson's group; independent replication limited.
Indications
- Interest in telomere biology and cellular aging research
- Support for healthy aging optimization protocols
Mechanism of Action
Cellular division causes progressive telomere attrition, limiting replicative capacity and triggering cellular senescence
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Epithalon | 5 mg | Daily for 10 days | First-time users, minimal cycle protocol |
| Epithalon | 10 mg | Daily for 10-20 days | Most common cycling protocol for telomere support |
| Epithalon | 10 mg | Twice daily for 20 days | Advanced protocol for experienced users |
Evidence Grade
GRADE C
Safety & Contraindications
- Clinical trial (n=162) reported zero adverse effects with parabulbar administration
- Cohort studies show good long-term safety over 6-12 years
- Most research from single research group (Khavinson); limited independent validation
- Recent 2025 study shows ALT pathway NOT activated in normal cells (cancer selectivity)
- Use sterile technique for all injections